I hope this message finds you well.
My name is Dr. Mukeshkumar Patel from Bostal LLC. I am writing to inquire about the availability of Atrasentan HCl. Could you please let us know whether this API is part of your commercial portfolio or currently under development in your R&D pipeline?
If it is in your R&D pipeline, we would appreciate it if you could share the expected timeline for the availability of an R&D sample. Additionally, please let us know whether you have plans to file a USDMF for this product, and if so, the anticipated timeline.
Your support and guidance would be highly appreciated, as it will greatly assist us in the development of this product.
Thank you in advance, and I look forward to your response.
Best regards
DR.Patel